Summary
Yuma Yokoi is a Senior Medical Director based in Tokyo with a decade of experience bridging clinical practice, regulatory review, and medical leadership in neuropsychiatry. His career spans frontline psychiatry, post‑doctoral research at Johns Hopkins, leadership in Japan’s National Center of Neurology and Psychiatry, and regulatory roles at the Pharmaceuticals and Medical Devices Agency before joining Eli Lilly. He holds an MD and PhD in Medicine, a clinical research certification from Johns Hopkins, and an MBA from Chicago Booth, enabling him to translate complex science into regulatory strategy and commercial decision‑making. Yuma is equally at home designing clinical programs and critiquing medical dossiers, with hands‑on experience in both research governance and policy implementation. Colleagues note his philosophical approach to balancing ethical and economic imperatives—summed up by his favorite Ninomiya quote—which informs pragmatic, patient‑centered strategies. He brings a rare combination of clinical credibility, regulatory acumen, and business training to drug development and medical affairs.
10 years of coding experience
Master of Business Administration - MBA, Master of Business Administration - MBA at The University of Chicago Booth School of Business
Doctor of Philosophy - PhD, Medicine, Doctor of Philosophy - PhD, Medicine at 山梨大学
Science of Clinical Investigation Certification, Clinical research, Science of Clinical Investigation Certification, Clinical research at Johns Hopkins Bloomberg School of Public Health
Bachelor of Medicine, Medicine, Bachelor of Medicine, Medicine at Tokyo Medical Dental University
English, Japanese